References
Falk E, Zhou J, Moller J: Homocysteine and atherothrombosis. Lipids 2001, 36:S3–S11.
Faraci FM, Lentz SR: Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 2004, 35:345–347.
Eikelboom JW, Hankey GJ, Anand SS, et al.: Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2000, 31:1069–1075.
Tanne D, Sela BA: Neurological implications of hyperhomocysteinemia in patients with atherothrombotic disease. Ital Heart J 2003, 4:577–579.
Sánchez-Moreno C, Jimenez-Conde J, Martin A: Stroke: roles of B vitamin, homocysteine and antioxidants. Nutr Res Rev 2009, 22:49–67.
McNulty H, Pentieva K, Hoey L, Ward M: Homocysteine, B-vitamins, and CVD. Proc Nutr Soc 2008, 67: 232–237.
Solomons NW: Food fortification with folic acid: has the other shoe dropped? Nutr Rev 2010, 65:512–515.
Spence JD: Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol 2007, 6:830–838.
Wrone EM, Hornberger JM, Zehnder JL, et al.: Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol 2004, 15:420–426.
Zoungas S, McGrath BP, Branley P, et al.: Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol 2006, 47:1108–1116.
House AA, Eliasziw M, Cattran DC, et al.: Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 2010, 303:1603–1609.
Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, et al.: Secondary prevention with folic acid: effects on clinical outcomes. J Am Coll Cardiol 2003, 41:2105–2113.
Liem AH, van Boven AJ, Veeger NJ, et al.: Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial. Int J Cardiol 2004, 93:175–179.
Lonn E, Yusuf S, Arnold MJ, et al.: Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006, 354:1567–1577.
Bønaa KH, Njølstad I, Ueland PM, et al.: Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006, 354:1578–1588.
Ebbing M, Bleie O, Ueland PM, et al.: Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamin after coronary angiography: a randomized controlled trial. JAMA 2010, 300:795–804.
Løland KH, Bleie O, Strand E, et al.: Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy. Am J Cardiol 2010, 105:1577–1184.
Ebbing M, Bønaa KH, Ueland PM, et al.: Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. J Intern Med 2010 Aug 4 [Epub ahead of print].
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Armitage JM, Bowman L, et al.: Effects of homocysteine-lowering with folic acid plus vitamine B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 2010, 303:2486–2494.
Albert C, Cook N, Gaziano JM, et al.: Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 2008, 299:2027–2036.
Potter K, Hankey GJ, Green DJ, et al.: The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis. BMC Cardiovasc Disord 2008, 8:24.
Toole JF, Malinow MR, Chambless LE, et al.: Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death. The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004, 291:565–575.
Yang Q, Botto LD, Erickson JD, et al.: Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 2006, 113:1335–1343.
Disclosure
No potential conflict of interest relevant to this article was reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Adams, H.P. Failure of Vitamin Supplementation to Lower the Risk of Recurrent Stroke. Curr Neurol Neurosci Rep 11, 1–5 (2011). https://doi.org/10.1007/s11910-010-0152-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11910-010-0152-0